Close
04-01

​EZDex is coming strongly and is bound to become the driving force of new finance

In this DeFi wave, there are various signs that the centralized exchange is obviously panicked in this DeFi shock. Although these head centralized exchanges have their own rules, the centralized governance method will inevitably have some phenomena that are not conducive to the development of the industry. Therefore, many blockchain technology geeks have invested in the research and developmen

04-01

DAVIS ELVIN launches new product DR05-01 with a brand new design concept

Sports watch brand DAVIS ELVIN announced the launch of the DR05 collection at the end of March this year and showed the photos of DR05-01. This collection continues the classic barrel-shaped appearance. The dial design and watch case texture have changed quite a lot, plus a new calendar function. Today, I will go through the details of the first watch DR05-01 of this collection.

04-01

MNS contract plan is coming!

​After brexit, the global financial system has experienced severe shocks. Based on the analysis of the current global economic and financial situation, skrill financial group in London is deeply aware of the need to deepen the reform of the current financial ecosystem and promote the process of digital finance construction. Therefore, moneybookers is launched to ease the economic and financial pre

04-01

Great Bay Bio Officially Launches AI Enabled Cell Culture Media Development Platform, AlfaMedX®

HONG KONG, March 31, 2021 - Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX® is created through the convergence between AI, big data and biotechnology, enabling the development of optimized cell culture media within a short timef

04-01

Great Bay Bio Officially Launches AI Enabled Cell Culture Media Development Platform, AlfaMedX®

HONG KONG, March 31, 2021 - Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX® is created through the convergence between AI, big data and biotechnology, enabling the development of optimized cell culture media within a short ti

Home Previous 333 334 335 336 337 338 339 Next Tail

10 Items Per Page (Page 336 / 397) Total 3966 Items

©copyright 2009-2020 Ritzaus Bureau      Contact Us   SiteMap